0.67% -0.0049

Avenue Therapeutics Inc (ATXI)

Überblick Nachrichten Preisverlauf Financials Warum fällt ATXI? Forum Prognose Aktiensplit

Finanzdaten der Avenue Therapeutics Inc-Aktie (ATXI)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Research and Development	143.58% 2.392	0.982	0.907	3.027	1.215
Operating Income/Loss	74.99% -3.708	-2.119	-2.068	-3.923	-6.429
Nonoperating Income/Loss	-0.641	-	2.581	-0.093	-1.173
Income/Loss From Continuing Operations Before Tax	804.86% -4.349	0.617	0.513	-4.016	-7.602
Income/Loss From Continuing Operations After Tax	804.86% -4.349	0.617	0.513	-4.016	-7.602
Net Income/Loss	804.86% -4.349	0.617	0.513	-4.016	-7.602
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	60.87% -0.009	-0.023	-0.013	-0.009	-0.066
Basic Average Shares	83.65% 0.562	3.4366	8.1142	-	5.5648
Basic Earnings Per Share	2,850% -15.40	0.56	0.06	-0.52	-1.35
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$37.01

1.84%

INCY

$87.57

0.30%

GMAB

$33.17

1.28%

BNTX

$105.14

0.06%

ONC

$316.42

0.50%

INSM

$165.76

1.57%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Offen in Reuters